These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1752989)

  • 21. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome.
    Lederer DJ; Kawut SM; Sonett JR; Vakiani E; Seward SL; White JG; Wilt JS; Marboe CC; Gahl WA; Arcasoy SM
    J Heart Lung Transplant; 2005 Oct; 24(10):1697-9. PubMed ID: 16210149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acquired hemophilia A associated with chronic myelomonocytic leukemia successfully treated by rituximab and azacitidine].
    Dartevel A; Aubanel S; Pica GM; Faurie P; Fauché C; Boué Y; Peigne V
    Rev Med Interne; 2018 Aug; 39(8):654-657. PubMed ID: 29653879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.
    Svensson PJ; Bergqvist PB; Juul KV; Berntorp E
    Blood Rev; 2014 May; 28(3):95-102. PubMed ID: 24703870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmopressin--a haemostatic drug: state-of-the-art review.
    Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case].
    Zelada J; Cantó G; Berkovits A; Diocares G; López A
    Rev Med Chil; 2015 Nov; 143(11):1490-3. PubMed ID: 26757875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE CORRECTION OF PROLONGED BLEEDING TIMES IN TWO BROTHERS BY PLATELET TRANSFUSIONS DESPITE NORMAL IN VITRO PLATELET TESTS.
    WHITE JG; YUNIS E; COLLIANDER M; KRIVIT W
    Pediatrics; 1964 Apr; 33():579-84. PubMed ID: 14166539
    [No Abstract]   [Full Text] [Related]  

  • 29. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass.
    de Prost D; Barbier-Boehm G; Hazebroucq J; Ibrahim H; Bielsky MC; Hvass U; Lacombe C; Français JL; Desmonts JM
    Thromb Haemost; 1992 Aug; 68(2):106-10. PubMed ID: 1412152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral intramonocytic and intraneutrophil leishmanias observed in a chronic myelomonocytic leukemia (CMMoL) patient.
    Fiorini M; Messina MF; Barracchia A
    Haematologica; 2002 Aug; 87(8):EIM21. PubMed ID: 12161378
    [No Abstract]   [Full Text] [Related]  

  • 31. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.
    Galton DA
    Leuk Lymphoma; 1992 Aug; 7(5-6):343-50. PubMed ID: 1493435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factor XI inhibitors : clinical and biological features].
    Billon S; Blouch MT; Escoffre-Barbe M; Niger CL; Abgrall JF; Roux AM
    Ann Biol Clin (Paris); 2001; 59(2):183-6. PubMed ID: 11282522
    [No Abstract]   [Full Text] [Related]  

  • 33. [Minimal hemorrhagic diathesis].
    Huc N; Wijns W; Droeshout I; Capel P
    Rev Med Brux; 1992 Oct; 13(8):307-8. PubMed ID: 1439383
    [No Abstract]   [Full Text] [Related]  

  • 34. Laboratory evaluation of patients with undiagnosed bleeding disorders.
    Alves GS; Orsi FA; Santiago-Bassora FD; Quaino SK; Montalvão SA; Paula EV; Annichino-Bizzacchi JM
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):500-5. PubMed ID: 26825625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemostatic problems in acute promyelocytic leukaemia.
    Arbuthnot C; Wilde JT
    Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasminogen activator inhibitor deficiency].
    Mimuro J
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):494-7. PubMed ID: 9833553
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic myelomonocytic leukemia and solid neoplasms: is it a causal or a fortuitous association?].
    Rovira M; Cervantes F; Lozano M; Ribera JM; Reverter JC; Rozman C
    Sangre (Barc); 1989 Jun; 34(3):207-9. PubMed ID: 2762983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Care of the critically ill child: the bleeding neonate.
    Glader BE; Buchanan GR
    Pediatrics; 1976 Oct; 58(4):548-55. PubMed ID: 972796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemorrhagic diathesis in patients with malignant neoplasms (author's transl)].
    Zöller H; Gross W; Schreiner W
    Med Klin; 1979 Nov; 74(46):1716-20. PubMed ID: 118327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome.
    McGrattan P; Humphreys M; Hull D; McMullin MF
    Ulster Med J; 2007 Sep; 76(3):131-5. PubMed ID: 17853637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.